CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Adjuvant Ganglioside GM2-KLH/QS-21 Vaccination Versus Observation After Resection of Primary Tumor > 1.5 mm in Patients With Stage II Melanoma: Results of the EORTC 18961 Randomized Phase III Trial
Author
Alan Spatz
Alexander M.M. Eggermont
+18Â more
Investigator brochure
Jeremy Marsden
Jones PC
Larissa Polders
Lars Bastholt
Lloyd KO
Lorenzo Borgognoni
Maria Grazia Bernengo
Mario Santinami
Michel Praet
Neville Davidson
Paolo A. Ascierto
Philippa Corrie
Piotr Rutkowski
Poulam M. Patel
Stefan Suciu
Steinar Aamdal
Wim H. Kruit
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref